06826 HAOHAI BIOTEC
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2025) | |||
| Current | 3.79X | Oper Margin | 10.6% |
|---|---|---|---|
| LT Debt/Equity | 1.2% | Net Margin | 10.3% |
| Total Debt/Equity | 7.4% | Return on Equity | 4.6% |
| Price/Book | 0.84X | Return on Assets | 3.7% |
| (HKD 22.240) | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
| Net Profit (MHKD) | 279.40 | 447.15 | 458.65 | 202.34 | 430.82 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -37.5 | -2.5 | +126.7 | -53.0 | +57.8 |
| Earnings Per Share (HKD) | 1.205 | 1.918 | 1.933 | 0.833 | 1.747 |
| Earnings Per Share Growth (%) | -37.2 | -0.8 | +132.1 | -52.3 | +58.8 |
| Dividend Per Share (HKD) | 1.106 | 1.094 | 0.785 | 0.315 | 0.586 |
| P/E* (X) | 18.45 | 11.59 | 11.51 | 26.71 | 12.73 |
| Yield (%) | 4.97 | 4.92 | 3.53 | 1.42 | 2.63 |
| Dividend Share (%) | 91.79 | 57.02 | 40.59 | 37.83 | 33.52 |
| Book NAV (HKD) | 26.619 | 25.703 | 25.941 | 25.363 | 28.390 |
| Auditors' Opinion | N/A | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2026-04-02 21:40:20
Latest Result
| (RMBMn) | 2025-12 | 2024-12 | Chg* (%) | 2023-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 2,446 | 2,680 | -8.7 | 2,635 |
| Operating Result | 239.236 | 465.159 | -48.6 | 507.177 |
| Associates | 0.01 | 0.986 | -99.0 | 0.456 |
| Profit Before Taxation | 239.246 | 466.145 | -48.7 | 508.26 |
| Taxation | 30.924 | 89.902 | -65.6 | 95.991 |
| Profit /( Loss) After Taxation | 208.322 | 376.243 | -44.6 | 412.269 |
| Minority Interests | -42.687 | -44.204 | -3.4 | -3.852 |
| Net Profit | 251.009 | 420.447 | -40.3 | 416.121 |
| Earnings Per Share () | 1.2053 | 1.9182 | -37.2 | 1.9327 |
| Dividend Per Share () | 1.1063 | 1.0937 | +1.2 | 0.7845 |
| Announcement Date | 2026-03-20 | 2025-03-21 | NA | 2024-03-08 |
* Annualised
Last Update Time: 2026-04-02 21:40:25
